Vernal Biosciences Showcases Cutting-Edge Innovations at the 11th International mRNA Health Conference in Berlin
Retrieved on:
Monday, October 30, 2023
Vernal Biosciences, a leading Contract Development and Manufacturing Organization (CDMO) specializing in mRNA and LNP manufacturing, proudly announces its participation in the 11th International mRNA Health Conference held in Berlin.
Key Points:
- Vernal Biosciences, a leading Contract Development and Manufacturing Organization (CDMO) specializing in mRNA and LNP manufacturing, proudly announces its participation in the 11th International mRNA Health Conference held in Berlin.
- At the conference, Vernal Biosciences will unveil three groundbreaking posters that highlight innovative advancements in mRNA technologies and the flexibility of Vernal’s platform process technologies.
- Dr. Christian Cobaugh, Chief Executive Officer at Vernal Biosciences, stated, "We are excited to share these groundbreaking findings at the 11th International mRNA Health Conference.
- The 11th International mRNA Health Conference is a premier platform for industry leaders and researchers to exchange ideas and drive innovations in mRNA therapeutics.